ZTABS develops computer vision systems for Zurich enterprises — medical imaging AI for diagnostic assistance under Swissmedic and EU MDR regulation, pharmaceutical production visual inspection meeting GMP validation requirements, and precision manufacturing quality control for Swiss watchmaking, micro-engineering, and medical device production where tolerances are measured in microns.
Switzerland's computer vision requirements sit at the intersection of extreme precision and extreme regulation. When a Swiss watchmaker needs a CV system to inspect watch components, the tolerance is 5-10 microns — a human hair is 70 microns. When a pharmaceutical company needs a CV system to inspect vial fill levels, the system must be validated under GMP (Good Manufacturing Practice) with documented IQ/OQ/PQ (Installation, Operational, Performance Qualification) — and any change to the model requires re-validation. When a medical imaging AI assists radiologists, it must achieve CE marking as a medical device under EU MDR, with clinical evidence demonstrating diagnostic performance. Swiss computer vision development operates under the most demanding combination of precision requirements and regulatory constraints in the world. A CV defect detection system for a German automotive supplier must meet ISO quality standards.
The same system for a Swiss pharmaceutical company must additionally meet FDA 21 CFR Part 11 (electronic records), Annex 11 (computerized systems), and GMP validation — a compliance burden that doubles the development effort and cost. A CV system for a Singapore electronics manufacturer needs to detect defects. The same system for a Swiss medical device manufacturer needs to detect defects AND produce documentation suitable for Swissmedic regulatory submission, including evidence that the system does not introduce new risks (per ISO 14971) and maintains consistent performance over time (per IEC 62304). The reward for navigating this complexity: Swiss industries pay premium rates for validated, regulation-compliant CV systems — and the Swiss market (pharmaceutical, medical device, watchmaking, precision engineering) represents global leaders in each category.
Zurich and Switzerland's computer vision demand is driven by pharmaceutical, medical devices, precision manufacturing, and the emerging autonomous mobility sector. Pharmaceutical visual inspection: Switzerland hosts the world's largest pharma companies (Novartis — Basel, Roche — Basel, Johnson & Johnson — Zug). Pharmaceutical production requires visual inspection at multiple stages: incoming raw material inspection (verifying identity and quality of active pharmaceutical ingredients and excipients), in-process inspection (tablet appearance, capsule integrity, vial fill levels, syringe assembly — all at production line speed), final product inspection (label verification — text accuracy, barcode readability, expiry date correctness, package integrity), and stability sample monitoring (visual inspection of samples stored under controlled conditions over months/years — detecting color changes, particulate formation, or degradation). Each inspection point must be GMP-validated: the CV system's performance must be documented, its accuracy must be verified against human inspection, and any change (software update, camera replacement, lighting change) requires re-validation.
Medical imaging AI: Switzerland's MedTech cluster (Zurich, Basel, Bern) develops AI for: radiology (chest X-ray analysis, mammography screening assistance, CT/MRI segmentation), pathology (digital pathology — analyzing tissue samples for cancer grading, biomarker quantification), ophthalmology (retinal imaging — diabetic retinopathy screening, glaucoma detection), and dermatology (skin lesion classification — melanoma detection). Medical imaging AI is typically Class IIa or IIb under EU MDR — requiring notified body conformity assessment, clinical evaluation, and post-market surveillance. Precision manufacturing: Swiss watchmaking (Swatch Group, Richemont, Rolex), micro-engineering (Tornos, Mikron), and medical device manufacturing (Medtronic, Sonova, Ypsomed) require CV inspection of components with micron-level tolerances. Watch components: gear teeth profile, surface finish, jewel bearing placement. Medical devices: implant surface quality, catheter tip geometry, stent strut dimensions.
Autonomous mobility: Switzerland's autonomous vehicle testing (autonomous buses in Sion, autonomous trucks in Gotthard corridor) and drone regulation (FOCA — Federal Office of Civil Aviation) create demand for perception CV systems — object detection, semantic segmentation, and depth estimation for autonomous navigation in Swiss alpine conditions (tunnels, mountain passes, snow).
Our Zurich computer vision development integrates regulatory compliance with precision engineering — delivering CV systems that meet Swiss quality expectations and regulatory requirements. Regulated CV development: (1) GMP-validated pharmaceutical inspection: we develop CV inspection systems following the GAMP 5 (Good Automated Manufacturing Practice) framework — risk-based validation that documents: user requirements specification (URS — what the inspection system must detect, at what sensitivity, with what throughput), functional specification (FS — how the system achieves the requirements), design specification (DS — technical architecture, model architecture, hardware specifications), IQ (Installation Qualification — verifying hardware is installed correctly, cameras are calibrated, lighting is positioned per specification), OQ (Operational Qualification — verifying the system operates correctly under defined conditions — across the full range of operating parameters), and PQ (Performance Qualification — verifying the system performs consistently in production conditions over an extended period — typically 3 production runs minimum).
Change control: any modification to a GMP-validated CV system (model update, camera replacement, software patch) triggers a change control process — risk assessment, re-validation scope determination, and documented re-validation execution. We design CV systems with modular validation — so a model update re-validates only the model performance, not the entire system hardware. (2) Medical device CV (EU MDR): for CV systems classified as medical devices, we implement: clinical evaluation (demonstrating the CV system's diagnostic performance against clinical ground truth — sensitivity, specificity, positive predictive value, negative predictive value), risk management per ISO 14971 (identifying risks: what happens if the CV system misses a finding? what happens if it produces a false positive?), software lifecycle per IEC 62304 (documented development, verification, and maintenance), and post-market surveillance plan (monitoring CV system performance in real-world clinical use — tracking diagnostic accuracy over time, collecting user feedback, monitoring incident reports).
Precision imaging: (1) Microscopy-grade optics: for Swiss precision manufacturing inspection, we specify industrial cameras with telecentric lenses (eliminating perspective distortion — critical for dimensional measurement), coaxial illumination (revealing surface defects that conventional lighting misses), and high-resolution sensors (20+ megapixel for micron-level feature detection). Camera selection is tailored to the inspection requirement — monochrome sensors for dimensional measurement, color sensors for surface defect detection, multispectral for material identification. (2) Sub-pixel measurement: Swiss precision demands often exceed single-pixel resolution. We implement sub-pixel edge detection algorithms that achieve measurement precision of 0.1 pixel — on a calibrated system, this translates to micron-level measurement accuracy. Calibration uses NIST-traceable reference standards for measurement traceability. (3) 3D inspection: for components with complex geometry (watch movements, medical implants, precision machined parts), we deploy structured light 3D scanning — projecting known light patterns onto the surface and reconstructing 3D geometry from the deformation.
3D inspection enables: dimensional verification against CAD models (comparing manufactured geometry to design specification), surface roughness measurement (critical for medical implants — Ra values determine biocompatibility), and assembly verification (confirming correct component placement in complex assemblies).
Free consultation — no commitment required.
A Swiss biologics manufacturer producing injectable medications (monoclonal antibodies in pre-filled vials — high-value products at CHF 800-2,000 per vial) needed to replace its semi-automated visual inspection system. The existing system combined: automated particle detection (a machine that spun vials and detected particulate matter using light scattering), followed by manual visual inspection (trained inspectors examining each vial for: fill level accuracy, vial integrity (cracks, chips), stopper seating, cap crimping, label presence and alignment, and cosmetic defects (scratches, stains on vial exterior)). The problems: (1) Inspection throughput: manual visual inspection limited throughput to 2,400 vials per hour per inspector. The production line produced 4,000 vials per hour — requiring 2 inspectors running in parallel, creating a bottleneck that slowed production during peak demand. (2) Inspector fatigue: 8-hour inspection shifts with required breaks every 30 minutes (industry best practice for visual inspection).
Even with breaks, inspector accuracy degraded measurably in hours 6-8 compared to hours 1-2 — studies at the facility showed 15% higher false negative rates (missed defects) in late-shift inspection. (3) Subjectivity: "acceptable" cosmetic defects (minor scratches, small stains) were judged subjectively. Different inspectors had different thresholds, creating inconsistent reject rates across shifts (ranging from 1.8% to 3.2% — a significant variance for a product worth CHF 800-2,000 per unit). (4) Regulatory documentation: manual inspection relied on inspector training records and periodic competency assessments. Regulatory auditors (Swissmedic, FDA) increasingly questioned whether manual visual inspection was sufficiently controlled and documented. The company wanted to demonstrate regulatory leadership by implementing validated automated inspection.
We developed a GMP-validated computer vision vial inspection system over 18 weeks: (1) Multi-camera inspection station: 8 synchronized cameras (4 Mpx Basler ace2 with telecentric lenses) arranged around a rotating vial holder: 2 side cameras (detecting cracks, chips, label placement, surface defects), 1 bottom camera (vial base integrity), 1 top camera (stopper seating, cap crimping quality), 2 meniscus cameras (fill level measurement through the transparent vial wall — detecting underfill and overfill with ±0.5% volume accuracy), and 2 label cameras (OCR reading lot number, expiry date, product name, barcode — verifying against batch record data). Controlled LED illumination (dark field for particle and crack detection, bright field for surface defects, backlighting for fill level) eliminated environmental lighting dependency.
(2) Multi-task CV model: the system runs 6 specialized models sequentially on each vial (total inference time: 120ms per vial — supporting 6,000 vials/hour throughput): fill level model (regression model predicting fill volume from meniscus image — trained on 8,000 images with calibrated fill volumes), crack/chip detection (object detection model identifying structural defects — trained on 5,000 defect images including synthetically generated crack patterns overlaid on clean vial images, because real defect images are rare for high-value biologics), stopper/cap model (classification model verifying correct stopper seating depth and cap crimping — trained on 12,000 images across 4 stopper/cap combinations the facility uses), label verification (OCR + layout verification — reading printed text and comparing against expected batch data, checking label alignment within ±1mm tolerance), surface defect detection (segmentation model identifying scratches, stains, and foreign material on vial exterior — trained with augmented data to handle the transparent/reflective properties of borosilicate glass), and overall classification (an ensemble model combining outputs from all 5 models to produce Accept/Reject/Review decisions — with configurable sensitivity thresholds per defect category).
(3) GMP validation package: complete GAMP 5 validation documentation: URS (23 user requirements covering inspection scope, accuracy targets, throughput requirements, and regulatory compliance), FS and DS (detailed system specification including model architectures, training data descriptions, and hardware specifications), IQ protocol and report (documenting hardware installation, camera calibration with NIST-traceable reference vials, and software installation verification), OQ protocol and report (testing system performance across the full operating range — fill level accuracy at minimum and maximum fill, defect detection at minimum and maximum line speed, performance with all product/vial/stopper combinations), PQ protocol and report (3 consecutive production runs demonstrating consistent performance — inspecting 12,000+ vials per run with comparison against parallel manual inspection), and validation summary report (consolidating all validation evidence for regulatory review). (4) Continuous monitoring: the system logs every inspection decision with annotated images — creating a complete audit trail.
Statistical process control charts track: reject rate over time (detecting drift from expected reject rate), defect category distribution (detecting shifts in defect types that might indicate production issues), and model confidence distribution (detecting degradation in model certainty that might indicate calibration drift or model degradation).
Inspection throughput: 2,400 vials/hour (manual, per inspector) → 6,000 vials/hour (automated). The production line bottleneck was eliminated — the inspection station now runs faster than the filling line, providing buffer capacity. Inspection consistency: reject rate variance across shifts reduced from 1.8-3.2% (manual) to 2.1-2.3% (automated) — the system applies identical criteria 24/7 regardless of operator, shift, or fatigue. Defect detection: the CV system detected 99.4% of known defects in a challenge test set (100 vials with known planted defects) — compared to 94.1% detection by the best human inspector and 89.3% by the average inspector. Critically: the CV system detected 100% of structural defects (cracks, chips) — the highest-risk defect category for patient safety. False reject rate: 0.8% (CV system) vs. 2.1% average (manual inspection).
At CHF 800-2,000 per vial, the reduced false reject rate recovers approximately CHF 520,000 annually in product that would have been incorrectly rejected by manual inspection. Regulatory response: Swissmedic inspectors reviewed the validated CV system during a routine GMP inspection and noted it as a "positive observation" — the validated system with complete documentation and continuous monitoring exceeded the regulatory expectation for visual inspection control. FDA pre-approval inspection for a new product similarly noted the CV inspection system favorably. Inspector redeployment: the 4 visual inspectors (2 per shift) were redeployed to upstream quality roles (in-process monitoring, environmental monitoring) — not laid off. The company had unfilled quality positions that the inspectors filled after retraining. Development cost: CHF 420,000 (including cameras, industrial PC, custom inspection station fabrication, software development, and GMP validation).
Annual savings: CHF 520,000 in reduced false rejects + CHF 340,000 in labor redeployment value + unquantified regulatory risk reduction. Payback: under 12 months.
Real-time detection, classification, and counting of objects in images and video streams.
Extract structured data from documents, invoices, receipts, and forms with high accuracy.
Automated visual inspection for manufacturing defect detection with sub-second processing.
Real-time video stream analysis for surveillance, traffic monitoring, and retail analytics.
Train domain-specific models on your data using YOLO, Detectron2, SAM, and custom architectures.
Deploy vision models on edge devices (Jetson, Coral), mobile, or cloud with optimized inference.
Zurich's computer vision market includes: pharmaceutical inspection specialists (Antares Vision — Italian, strong in pharma serialization; Syntegon/Bosch Packaging — integrated packaging and inspection; VITRONIC — German industrial vision), medical imaging AI companies (Sophia Genetics, RetinAI — Swiss medical imaging AI startups), precision manufacturing vision (Zeiss — industrial metrology with vision capability, Keyence — Japanese industrial vision with Swiss sales), and research (ETH Zurich Computer Vision Lab — world-class CV research). The gap: pharmaceutical inspection vendors sell standardized inspection systems — effective for common defects but requiring extensive customization for novel products or inspection requirements. Medical imaging AI startups focus on specific clinical applications but may not navigate the regulatory pathway efficiently. Industrial vision vendors provide hardware and basic software but not the custom model development and GMP validation that Swiss pharmaceutical and medical device companies require.
ZTABS delivers custom CV systems with integrated regulatory compliance — from model development through GMP validation documentation.
Computer vision development in Zurich ranges from CHF 60,000 for focused inspection applications to CHF 500,000+ for GMP-validated pharmaceutical inspection systems. Pharmaceutical vial inspection (as in the case study): CHF 420,000 including hardware and GMP validation. Medical imaging AI (CE-marked): CHF 200,000-400,000 (development) + CHF 80,000-150,000 (clinical evaluation and regulatory submission). Precision manufacturing inspection: CHF 80,000-200,000. Watch component micro-inspection: CHF 100,000-250,000.
Verified reviews from real client engagements — sourced from our public testimonial archive and Clutch profile.
My experience is throughout positive. Communication, service, the short response times and the flawless execution of a challenging topic was absolutely great. ZTABS is definitely my first choice again.
Christian Neff
Bank Software Advisory · Bank Software Advisory
Fintech
Fantastic Agency! I couldn't fault them even if I tried. They always go above and beyond to meet your expectations and always produces quality work. Thank you ZTABS.
Stephanie Kal
CEO · Beauty Finder Australia
Marketplace
It has been great working with ZTABS. They bounce off the ideas along the way. Amazing Experience.
Joel Rowe
CEO · Drill Quoter
Marketplace
We don't just contract. We ship and operate our own software. 23 products in production.
Common questions about computer vision development for Zurich businesses
If the CV system inspects pharmaceutical products in a GMP-regulated manufacturing environment: yes. GMP validation (GAMP 5 framework) is required for any computerized system that affects product quality. This includes visual inspection systems, measurement systems, and any system that generates data used in batch release decisions. We manage the complete validation lifecycle: URS, FS/DS, IQ/OQ/PQ protocols and reports.
ZTABS is a remote-first computer vision development agency serving Houston businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Energy & Oil/Gas, Healthcare & Biotech, Aerospace & Defense companies in Houston, TX via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision Development in New York, NYZTABS is a remote-first computer vision development agency serving New York businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Finance & Fintech, Media & Advertising, Fashion & Retail companies in New York, NY via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision Development in Los Angeles, CAZTABS is a remote-first computer vision development agency serving Los Angeles businesses — including object detection & classification, document processing & ocr, quality inspection systems. We work with Entertainment & Media, E-commerce & DTC Brands, Gaming & AR/VR companies in Los Angeles, CA via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Web Development in Zurich, SwitzerlandZTABS is a remote-first web development agency serving Zurich businesses — including full-stack development, progressive web apps, api development. We work with FinTech & Banking, Crypto & Blockchain, Pharma & MedTech companies in Zurich, Switzerland via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Web Design in Zurich, SwitzerlandZTABS is a remote-first web design agency serving Zurich businesses — including ui/ux design, responsive design, custom interfaces. We work with FinTech & Banking, Crypto & Blockchain, Pharma & MedTech companies in Zurich, Switzerland via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
AI Development in Zurich, SwitzerlandZTABS is a remote-first AI development agency serving Zurich businesses — including llm integration & fine-tuning, ai agents & automation, rag & knowledge systems. We work with FinTech & Banking, Crypto & Blockchain, Pharma & MedTech companies in Zurich, Switzerland via timezone-aligned engineers and async workflows; we do not have a local office, and we are explicit about that with every client.
Computer Vision DevelopmentLearn more about our computer vision development services nationwide.
Partner with ZTABS for expert computer vision development in Zurich. Get a free consultation today.
